R414-60B-6. P&T Committee Responsibilities and Functions

  (1) The P&T Committee functions as a professional and technical advisory board to DMHF in the formulation of a PDL.

  (2) P&T Committee recommendations must:

  (a) represent the majority vote at meetings in which a majority of voting members are present; and

  (b) include votes by at least one committee member from the group identified in Subsection R414-60B-5(3) and one member from the group identified in Subsection R414-60B-5(4)

  (3) The P&T Committee manager shall schedule meetings, set agendas, provide meeting materials, keep minutes, record committee business, notify the Director when vacancies occur, provide meeting notices, and coordinate functions between the committee and DMHF.

  (4) Notice for a P&T Committee meeting shall be given in accordance with applicable law.

  (5) The P&T Committee chairperson shall conduct all meetings. The P&T Committee manager shall conduct meetings if the chairperson is not present.

  (6) P&T Committee meetings shall occur at least quarterly.

  (7) P&T Committee meetings shall be open to the public except when meeting in executive session.

  (8) The committee shall:

  (a) review drug classes and make recommendations to DMHF for PDL implementation;

  (b) review new drugs, new drug classes or both, to make recommendations to DMHF for PDL implementation;

  (c) review drugs or drug classes as DMHF assigns or requests;

  (d) review drugs within a therapeutic class and make a recommendation to DMHF for the preferred drug or drugs within the therapeutic class; and

  (e) review evidence based criteria and drug information.